Clinical Trial Update: UPLYFT For Lymphoma Survivors [NA]

View source ↗

Summary

Clinical trial is recruiting to evaluate UPLYFT for lymphoma survivors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• UPLYFT

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Lymphoma, Survivorship | NA | Status: RECRUITING